Laserfiche WebLink
Metadata
Document management portal powered by Laserfiche WebLink 9 © 1998-2015 Laserfiche. All rights reserved.
j . The GRANTEE shall ensure that all laboratory testing procedures follow the analytical methods <br /> as approved in the planning document (see Section 6 ) . <br /> k . The GRANTEE shall ensure that the all laboratory quality control measures are consistent with <br /> Chapter 5 of the NELAC standards . <br /> I . In addition , the GRANTEE shall ensure that the quality control requirements specified in the <br /> attached addenda are followed . <br /> m . The GRANTEE shall ensure that all sample results are calculated according to the procedures <br /> specified in the analytical methods approved in the planning document . <br /> 3 . FIELD ACTIVITIES <br /> a . "Sample" refers to samples that have been either collected or analyzed under the terms of this <br /> Agreement . <br /> b . The GRANTEE shall ensure that all sample collection and field testing activities are performed in <br /> accordance with the Department's "Standard Operating Procedures for Field Activities" ( DEP- <br /> SOP-001 /01 , February 1 , 2004 ) . The specific standard operating procedures ( SOPs ) to be used <br /> for this Agreement shall be cited in the planning document (see Section 6 ) . <br /> C. Any non -standard field procedure shall be submitted for review and approval to the DEP project <br /> manager in accordance with section FA 2000 of DEP-SOP-001 /01 . All non-standard procedures <br /> and methods must be approved by the DEP project manager before use under this Agreement <br /> and must be cited or described in the planning document. <br /> d . Per the quality control measures outlined in the DEP SOPs ( FQ 1000 and the calibration <br /> requirements of the FT-series for field testing ) , the GRANTEE shall ensure that the following field <br /> quality controls (and any additional quality control measures specified in the addenda ) are <br /> incorporated into the project design : <br /> ( i ) Matrix- Related Quality Controls - The GRANTEE shall ensure that the laboratory is provided <br /> with sufficient sample volume to analyze at least one set of matrix spikes and either matrix <br /> spike duplicates or laboratory duplicates as follows : <br /> ( 1 ) The first time a sample from a sample collection matrix (see Table FA 1000- 1 ) <br /> is <br /> collected ; <br /> (2 ) One in each additional 20 samples of the sample collection matrix , after the first 20 <br /> samples ; and <br /> (3 ) The last time samples are collected for the sample collection matrix . <br /> ( ii ) Field -generated Quality Control duplicates or replicates (not to be confused with laboratory <br /> duplicates ) shall be collected and analyzed at a frequency of 5 % of the total number of <br /> samples collected for each matrix/analyte combination (see FQ 1220 ) . <br /> ( 1 ) All field duplicate results greater than the contracted PQL should agree within 20 % RPD <br /> for each measured analyte . In the event that the field duplicate agreement is not <br /> observed , the GRANTEE shall investigate and attempt to determine the cause of poor <br /> precision . The outcome of these investigations shall be reported , including the corrective <br /> measures taken to minimize future problems . <br /> ( iii ) Field-Generated Quality Control ( QC ) Blanks — Blanks associated with field activities as <br /> defined in FQ 1210 of the DEP SOPs shall be collected according to the requirements of FQ <br /> 1230 . <br /> ( 1 ) If an analyte detected in the sample is also found in any field -generated QC blank that is <br /> associated with the sample , the GRANTEE shall investigate and attempt to determine the <br /> cause of the QC blank contamination . The outcome of this investigation shall be reported <br /> and shall include a discussion of the corrective measures taken to minimize future <br /> occurrences of QC blank contamination . <br /> (2 ) If an analyte detected in the sample is also found in any field -generated QC blank that is <br /> associated with the sample , the GRANTEE shall ensure that the analyte in the affected <br /> sample is reported as estimated ("J" with a narrative explanation ) unless the analyte <br /> concentration in the affected sample is at least 10 times the reported QC blank value <br /> concentration . <br /> ( iv) The GRANTEE shall identify a second laboratory that meets the requirements in Section 1 <br /> and shall arrange to have split samples collected using the sampling procedures specified in <br /> the Agreement and analyzed by the primary and secondary laboratories . Split samples shall <br /> Revised 3/05 <br /> DEP Agreement No. G0143 , Attachment H , Page 2 of 11 <br />